American College of Neuropsychopharmacology Inc. Neuropsychopharmacology
subscribe to npp
SEARCH
Advanced search
My Account E-alerts Subscribe Register Help
Journal home
Current Issue
Advance Online Publication
Archive
Online sample issue FREE!
Author index
Keyword index
For authors
Editorial Board
Instructions for authors
Aims and scope
Indexed in
Author queries
Online Submission
Customer Services
Subscription information
Journal prices
Order sample issue
Purchase articles,
reprints & permissions
Advertising
Contact NPG
nature.com
Original Article
Neuropsychopharmacology (1999) 21 368-371.10.1038/sj.npp.1395292

Global Cerebral Blood Flow Increase Reveals Focal Hypoperfusion in Schizophrenia

Stephan F Taylor1,3 MD, Rajiv Tandon1 MD and Robert A Koeppe2 Ph.D
1Departments of Psychiatry, Veterans Administration Medical Center, Ann Arbor, MI USA
2Internal Medicine Division of Nuclear Medicine, Veterans Administration Medical Center, Ann Arbor, MI USA
3University of Michigan, and Department of Psychiatry, Veterans Administration Medical Center, Ann Arbor, MI USA

Correspondence: Dr Stephan F Taylor, Department of Psychiatry, University of Michigan Medical Center, UH 9D Box 0118, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0118

This work was previously presented at the Second International Conference on Functional Mapping of the Human Brain, Boston, MA, in June, 1996.
ABSTRACT

Recent functional neuroimaging strategies have evaluated cerebral blood flow (CBF) to determine specific sites of action of pharmacologic agents. Since many pharmacologic agents change global CBF, we investigated the effects of global CBF changes on regional perfusion with acetazolamide, which increases global CBF via non-neuronal mechanisms. We used the [15O]PET technique to measure CBF before and after we infused 8 schizophrenic patients and 10 healthy control subjects with acetazolamide. The rostral anterior cingulate cortex demonstrated a greater perfusion increase in the schizophrenic subjects after acetazolamide infusion, relative to other areas of the brain. During the baseline condition, this area showed relative hypoperfusion in our sample of schizophrenic subjects, consistent with previous functional neuroimaging studies. The results demonstrate the need for caution in interpreting CBF changes after pharmacologic challenge, because global CBF changes can confound the assessment of regionally-specific pharmacologic action.

Keywords: Schizophrenia; Cerebrovascular circulation; Emission computed tomography; Acetazolamide; Gyrus cinguli
  top go to top
Article Links
Send to a friend Send to a friend
Download PDF Download PDF
Full Text Full Text
 Next Article Next Article
 Previous Article Previous Article
 Table of Contents Table of Contents
Privacy Policy Copyright © 1999 by the American College of Neuropsychopharmacology